Mostrar el registro sencillo del ítem

Vitamin D receptor genetic polymorphisms and the risk of multiple sclerosis: A systematic review and meta-analysis

dc.contributor.authorMohammadi A.
dc.contributor.authorAzarnezhad A.
dc.contributor.authorKhanbabaei H.
dc.contributor.authorIzadpanah E.
dc.contributor.authorAbdollahzadeh R.
dc.contributor.authorBarreto G.E.
dc.contributor.authorSahebkar A.
dc.date.accessioned2020-09-02T22:23:04Z
dc.date.available2020-09-02T22:23:04Z
dc.date.issued2020
dc.identifier10.1016/j.steroids.2020.108615
dc.identifier.citation158, , -
dc.identifier.issn0039128X
dc.identifier.urihttps://hdl.handle.net/20.500.12728/5356
dc.descriptionThere are conflicting results regarding the exact effect of the vitamin D receptor (VDR) gene polymorphisms on the susceptibility to multiple sclerosis (MS). Therefore, we aimed to investigate the impact of four major studied VDR gene polymorphisms consisting of ApaI, BsmI, FokI, and TaqI on the risk of MS in the Iranian population. A literature search was performed in various databases to find case-control studies evaluating the association between VDR gene polymorphisms and MS risk in Iran. Data were extracted and odds ratios (OR) with 95% confidence intervals (CI) were calculated. Subgroup analyze was performed to detect potential sources of heterogeneity. A total of 1206 cases and 1402 controls in nine case-control studies were included. ApaI was the only variant which showed statistically significant relation in allelic (OR = 0.54 (95% CI: 0.37–0.79); P = 0.00), homozygote (OR = 3.48 (95% CI: 1.7–6.9); P = 0.00), dominant (OR = 0.56 (95% CI: 0.3–0.79); P = 0.01), and recessive (OR = 0.35 (95% CI: 0.18–0.66); P = 0.00) models. The TaqI polymorphism showed a significant negative association with MS only in the homozygote model (OR = 0.28 (95% CI: 0.08–0.9); P = 0.04). The BsmI polymorphism also showed significant relation in allelic (OR = 0.69 (95% CI: 0.51–0.94); P = 0.01), homozygote (OR = 0.46 (95% CI: 0.25–0.86); P = 0.01), and recessive OR = 0.56 (95% CI: 0.39–0.8); P = 0.00) models after performing sensitivity analysis. FokI polymorphism showed no significant association with MS risk. ApaI and TaqI TT genotype were found contributing to MS susceptibility and BsmI and FokI showed no relation with MS susceptibility in the Iranian population. © 2020 Elsevier Inc.
dc.language.isoen
dc.publisherElsevier Inc.
dc.subjectIranian population
dc.subjectMeta-analysis
dc.subjectMultiple sclerosis
dc.subjectVitamin D receptor
dc.subjectvitamin D receptor
dc.subjectallele
dc.subjectdata base
dc.subjectdata extraction
dc.subjectevaluation study
dc.subjectgenetic heterogeneity
dc.subjectgenetic polymorphism
dc.subjectgenotype
dc.subjecthomozygote
dc.subjecthuman
dc.subjectIranian people
dc.subjectmeta analysis
dc.subjectmultiple sclerosis
dc.subjectodds ratio
dc.subjectReview
dc.subjectrisk assessment
dc.subjectsensitivity analysis
dc.subjectsystematic review
dc.titleVitamin D receptor genetic polymorphisms and the risk of multiple sclerosis: A systematic review and meta-analysis
dc.typeReview


Ficheros en el ítem

Thumbnail
Nombre:
item_2-s2.0-85080046927.pdf
Tamaño:
2.950Kb
Formato:
PDF
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem